Generex Biotechnology Introduces Pantheon Medical,

Generex Biotechnology Introduces Pantheon Medical, the Newest Member of the NuGenerex Family of Companies
GlobeNewswire•July 31, 2019
Pantheon Medical Line of Orthopedic Implants
“All-in-One” Foot & Ankle Kits
https://pantheonortho.com
MIRAMAR, Fla., July 31, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (www.generex.com) (GNBT) is proud to introduce Pantheon Medical (https://pantheonortho.com) as the newest member of the NuGenerex family of subsidiary companies. Pantheon is a manufacturer of orthopedic foot & ankle surgery kits that offer physician friendly “all-in-one,” integrated surgical kits that include plates, screws, and tools required for orthopedic surgeons and podiatrists conducting foot and ankle surgeries.

The orthopedic implants market was estimated at nearly $46 billion in 2017 is expected to reach $66 billion by 2025, according to a recent report by Allied Market Research (www.alliedmarketresearch.com/orthopedic-implants-market). The number of orthopedic surgeries, including hip & knee replacements, ankle & foot repairs and corrections, and fracture repairs continue to climb due to the aging population and the increased prevalence of obesity, which can lead to joint problems, particularly in the lower extremities.

Pantheon products are developed by combining decades of engineering and business experience with the talent and knowledge of leading orthopedic surgeons. The team continually collaborates with an international panel of foot and ankle surgeon experts to create efficiency, excellence and breakthrough solutions. Pantheon’s mission is to deliver premium implants, instructive surgeon medical education programs and to help facilities reduce costs and time required for case set up and inventory management.

“We are thrilled to welcome Travis H. Bird to the NuGenerex team,” said Joe Moscato Generex President & Chief Executive Officer. “Pantheon’s portfolio and distribution platforms are uniquely positioned to address the needs of orthopedic surgeons and podiatrists who are part of the NuGenerex Distribution Solutions MSO network, demonstrating our corporate commitment to foster cross-company synergies that generate sales through our proprietary distribution channels. We look forward to working with Travis and his team.”

Travis H. Bird, President & CEO of Pantheon Medical commented on joining Generex, “We are excited for the possibilities as we merge Pantheon into the NuGenerex family of companies. The orthopedic surgery market is growing rapidly and in need of new solutions that combine the state-of-the-art orthopedic implants, on demand ordering and distribution, and exceptional service to deliver the best possible outcomes for physicians and patients. Pantheon is also developing proprietary surgical systems to expand our product line. Over the next couple of years Pantheon will be developing a number of new product lines for submission to the FDA for 510K clearance, including cannulated screws and surgical staples, a proprietary hammertoe system, and new biologic products. The physician networks that we are building through NuGenerex not only provide proprietary market channels to facilitate product distribution, but also physician researchers who can advance the aims of our exciting development programs. We look forward to working with Joe and his team at Generex.”